Sterility, Endotoxin & Purity Explained

A literacy explainer on three different quality concepts that are routinely treated as interchangeable in vendor marketing.

Educational research-literacy content only. Not medical advice, not dosing guidance, not sourcing advice, and not a protocol for human or animal use. See our responsible information policy.

See also our companion page in the research governance hub: purity, sterility, endotoxin & contamination. This page extends that with a focus on the safety implications.

Purity (chemical)

Purity measures the fraction of intended compound. A 99% purity figure says nothing about what the other 1% is — that could be a related synthetic intermediate, a structurally similar contaminant, or, less commonly, something further removed.

Sterility (microbiological)

Sterility is the absence of viable microbes. It is achieved by sterile filtration or terminal sterilisation, and is verified by microbiological testing. Pharmaceutical injectables are sterile by definition. Research-grade peptides are typically not guaranteed sterile, even when handled cleanly.

Endotoxin (post-sterility)

Endotoxins are LPS fragments shed by Gram-negative bacteria. They survive sterilisation. They can trigger fever, hypotension, and severe inflammatory responses. Pharmaceutical-grade material is tested by the Limulus Amebocyte Lysate (LAL) assay; research-grade material usually is not.

Why this matters for any route of administration

For injectable use specifically, sterility and endotoxin matter enormously. A “high purity” vial can still introduce viable microorganisms or endotoxin into the body. This is one of the independent reasons why injection-route research with research-grade material is higher risk than the labelling suggests. See: why injectable route research is higher risk.